Related Experiment Video
Updated: Jul 19, 2026

Artificial RNA Polymerase II Elongation Complexes for Dissecting Co-transcriptional RNA Processing Events
Published on: May 13, 2019
Novel modulators of poly(ADP-ribose) polymerase
Csaba Szabo1, Pal Pacher, Raymond A Swanson
1Department of Surgery, University of Medicine and Dentistry, New Jersey Medical School, 185 South Orange Avenue, University Heights Newark, NJ 07103, USA. szabocsaba@aol.com
Abstract:
The nuclear enzyme poly(ADP-ribose) polymerase (PARP)-1 has an important role in regulating cell death and cellular responses to DNA repair. Pharmacological inhibitors of PARP have entered clinical testing as cytoprotective agents in cardiovascular diseases and as adjunct antitumor therapeutics. Initially, it was assumed that the regulation of PARP occurs primarily at the level of DNA breakage: recognition of DNA breaks was considered to be the primary regulator (activator) or the catalytic activity of PARP. Recent studies have provided evidence that PARP-1 activity can also be modulated by several endogenous factors, including various kinases, purines and caffeine metabolites. There is a gender difference in the contribution of PARP-1 to stroke and inflammatory responses, which is due, at least in part, to endogenous estrogen levels. Several tetracycline antibiotics are also potent PARP-1 inhibitors. In this article, we present an overview of novel PARP-1 modulators.
Insights
Poly(ADP-ribose) polymerase (PARP)-1 regulates DNA repair and cell death. Novel modulators, including endogenous factors and tetracyclines, offer new therapeutic avenues beyond traditional DNA break activation.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Poly(ADP-ribose) polymerase (PARP)-1 is a nuclear enzyme crucial for DNA repair and cell death regulation.
- PARP inhibitors are investigated as cardiovascular cytoprotective and antitumor agents.
- PARP-1 regulation was initially thought to be solely DNA break-dependent.
Purpose of the Study:
- To provide an overview of novel poly(ADP-ribose) polymerase (PARP)-1 modulators.
- To explore endogenous and exogenous factors influencing PARP-1 activity.
- To highlight emerging therapeutic strategies targeting PARP-1.
Main Methods:
- Review of recent scientific literature on PARP-1 regulation.
- Analysis of studies investigating endogenous PARP-1 modulators (kinases, purines, caffeine metabolites, estrogens).
- Examination of pharmacological PARP-1 inhibitors, including tetracycline antibiotics.
Main Results:
- PARP-1 activity is modulated by various endogenous factors beyond DNA breaks.
- Endogenous estrogen levels contribute to gender differences in PARP-1's role in stroke and inflammation.
- Several tetracycline antibiotics demonstrate potent PARP-1 inhibitory effects.
Conclusions:
- PARP-1 regulation is more complex than previously understood, involving multiple endogenous and exogenous factors.
- Novel PARP-1 modulators present diverse therapeutic opportunities.
- Further research into these modulators could lead to advanced treatments for various diseases.
Related Concept Videos
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...

